PHC Corporation and CCRM have signed a Master Collaboration Agreement to collaborate on developing primary T-cell expansion culture processes that aim to expedite the manufacturing of cell and gene therapy (CGT) products. This joint endeavor will combine LiCellGrow, PHC’s under-development cell expansion system, with CCRM’s extensive expertise in regenerative medicine and biomanufacturing to establish novel culture processes that enhance cell culture efficiency and quality for CGTs. Chikar...